Epigenetic plasticity and the hallmarks of cancer

Cited by (1,001)

Items 401–500 of 1,001

1. Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion
   Li-Lian Gan, Ling‐Wei Hii, Shew Fung Wong, Chee‐Onn Leong, Chun‐Wai Mai · 2020 · Cancers
2. Integrative analysis reveals novel driver genes and molecular subclasses of hepatocellular carcinoma
   Li-Guang Yang, Zhengtao Zhang, Yi-Di Sun, Shi-Chao Pang, Qianlan Yao, Ping Lin, Jinming Cheng, Jia Li, Guo-Hui Ding, L. Hui et al. · 2020 · Aging
3. Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response
   Tengda Zhao, Xue‐Ping Wang, Liwu Fu, Ke Yang · 2022 · Cancer Drug Resistance
4. Mechanisms Controlling MicroRNA Expression in Tumor
   Shipeng Chen, Ya Wang, Dongmei Li, Hui Wang, Xu Zhao, Jing Yang, Longqing Chen, Mengmeng Guo, Juanjuan Zhao, Chao Chen et al. · 2022 · Cells
5. Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
   Weihuan Shao, Yiran Yao, Ludi Yang, Xiaoran Li, Tongxin Ge, Yue Zheng, Qiuyi Zhu, Shengfang Ge, Xiang Gu, Renbing Jia et al. · 2024 · Experimental Hematology and Oncology
6. An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs
   Richard H. Chapple, Xueying Liu, Sivaraman Natarajan, Margaret I.M. Alexander, Yuna Kim, Anand G. Patel, Christy W. LaFlamme, Min Pan, William C. Wright, Hyeong-Min Lee et al. · 2024 · Genome biology
7. Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells
   Sreeharsha Gurrapu, Luca Tamagnone · 2019 · Trends in Molecular Medicine
8. The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma
   Ana Lameirinhas, Vera Miranda‐Gonçalves, Rui Henrique, Cármen Jerónimo · 2019 · Genes
9. A multiscale model of epigenetic heterogeneity-driven cell fate decision-making
   Núria Folguera-Blasco, Rubén Perez‐Carrasco, Elisabet Cuyàs, Javier Abel Menéndez, Tomás Alarcón · 2019 · PLoS Computational Biology
10. Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity
    Javier Abel Menéndez · 2020 · Biomolecules
11. MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity
    Junyi Zheng, Chen-Yu Wang, Chuan Gao, Qiong Xiao, Cheng‐Wei Huang, Min Wu, Lianyun Li · 2021 · Cell Death and Disease
12. Epigenetic “Drivers” of Cancer
    Alessio Butera, Gerry Melino, Ivano Amelio · 2021 · Journal of Molecular Biology
13. Structural variation cooperates with permissive chromatin to control enhancer hijacking–mediated oncogenic transcription
    G. Botten, Yuannyu Zhang, Kseniia Dudnyk, Y. Kim, Xin Liu, Jacob T. Sanders, Aygun Imanci, N. Droin, Hui Cao, Pranita Kaphle et al. · 2022 · Blood
14. Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model
    Núria Folguera-Blasco, Elisabet Cuyàs, Javier Abel Menéndez, Tomás Alarcón · 2018 · PLoS Computational Biology
15. Network Inference Analysis Identifies SETDB1 as a Key Regulator for Reverting Colorectal Cancer Cells into Differentiated Normal-Like Cells
    Soobeom Lee, Chansu Lee, Chae Young Hwang, Dongsan Kim, Young-Hyun Han, Sung Noh Hong, Seok‐Hyung Kim, Kwang‐Hyun Cho · 2020 · Molecular Cancer Research
16. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity
    Sebastian M. B. Nijman · 2020 · Trends in cancer
17. Metabolic cost of rapid adaptation of single yeast cells
    Gabrielle Woronoff, Philippe Nghe, Jean Baudry, Laurent Boitard, Erez Braun, Andrew D. Griffiths, Jérôme Bibette · 2020 · Proceedings of the National Academy of Sciences
18. LncRNA NEAT1/miR-129/Bcl-2 signaling axis contributes to HDAC inhibitor tolerance in nasopharyngeal cancer
    Fei Xue, You Cheng, Li Xu, Chuan Tian, Hongye Jiao, Rui Wang, Xia Gao · 2020 · Aging
19. Dynamics of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genes
    Mohamed Belhocine, Mathieu Simonin, José David Abad Flores, Agata Cieślak, Iris Manosalva, Lydie C. Pradel, Charlotte L. Smith, Ève-Lyne Mathieu, Guillaume Charbonnier, Joost H.A. Martens et al. · 2021 · Genome Research
20. EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
    Pierre Romero, Laia Richart, Setareh Aflaki, Ambre Petitalot, Megan Burton, Audrey Michaud, Julien Masliah‐Planchon, Frédérique Kuhnowski, Samuel Le Cam, Carlos Baliñas-Gavira et al. · 2024 · Nature Communications
21. Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
    Elisabeth A. Pedersen, Monique Elise Verhaegen, Mallory Joseph, Kelly L. Harms, Paul W. Harms · 2024 · Frontiers in Oncology
22. Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways
    Aishwarya Jaiswal, Sanah Shrivastav, Hemant Ritturaj Kushwaha, Rupesh Chaturvedi, Rana Pratap Singh · 2024 · Cell Communication and Signaling
23. H3K18 lactylation-mediated nucleotide-binding oligomerization domain-2 (NOD2) expression promotes bilirubin-induced pyroptosis of astrocytes
    Jing Li, Siyu Li, Qian Sun, Ling Li, Yan Zhang, Ziyu Hua · 2025 · Journal of Neuroinflammation
24. Codependency of Metabolism and Epigenetics Drives Cancer Progression: A Review
    Kenta Masui, Mio Harachi, Webster K. Cavenee, Paul S. Mischel, Noriyuki Shibata · 2020 · ACTA HISTOCHEMICA ET CYTOCHEMICA
25. Cell plasticity in cancer: A complex interplay of genetic, epigenetic mechanisms and tumor micro-environment
    Santosh Shenoy · 2020 · Surgical Oncology
26. 5‐Hydroxymethylcytosine signature in circulating cell‐free DNA as a potential diagnostic factor for early‐stage colorectal cancer and precancerous adenoma
    Zewen Xiao, Wendy Yi-Ying Wu, Chunlong Wu, Man Li, Fu-Ming Sun, Lu Zheng, Gao-Jing Liu, Xiaoling Li, Zhiyuan Yun, Jiebing Tang et al. · 2020 · Molecular Oncology
27. Epigenetic Regulation of Cell-Fate Changes That Determine Adult Liver Regeneration After Injury
    Luigi Aloia · 2021 · Frontiers in Cell and Developmental Biology
28. EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities
    Ozlem Yedier-Bayram, Bengul Gokbayrak, Alişan Kayabölen, Ali Cenk Aksu, Ayşe Derya Cavga, Ahmet Cingöz, Ezgi Yağmur Kala, Göktuğ Karabiyik, Rauf Günsay, Beril Esin et al. · 2022 · Cell Death and Disease
29. Pan-cancer landscape of epigenetic factor expression predicts tumor outcome
    Michael W. Cheng, Mithun Mitra, Hilary A. Coller · 2023 · Communications Biology
30. Neonatal Colonic Inflammation Epigenetically Aggravates Epithelial Inflammatory Responses to Injury in Adult Life
    Xiaoying S. Zhong, John H. Winston, Xiu‐Ju Luo, Kevin T. Kline, Syed Z. Nayeem, Yingzi Cong, Tor Savidge, Roderick H. Dashwood, Don W. Powell, Qingjie Li · 2018 · Cellular and Molecular Gastroenterology and Hepatology
31. On epigenetic stochasticity, entropy and cancer risk
    Andrew Erich Teschendorff · 2024 · Philosophical Transactions of the Royal Society B Biological Sciences
32. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
    Lenka Trnkova, Verona Buociková, Michal Mego, Andrea Čumová, Monika Buríková, Martin Boháč, Svetlana Miklikova, Marina Cihova, Božena Smolková · 2024 · Biomedicine & Pharmacotherapy
33. A Positive Feedback Loop Between c-Myc Upregulation, Glycolytic Shift, and Histone Acetylation Enhances Cancer Stem Cell-like Property and Tumorigenicity of Cr(VI)-transformed Cells
    Marco Clementino, Jie Xie, Ping Yang, Yunfei Li, Hsuan-Pei Lin, William Fenske, Hua Tao, Kazuya Kondo, Chengfeng Yang, Zhishan Wang · 2020 · Toxicological Sciences
34. Targeting Epigenetic protein–protein Interactions With small-molecule Inhibitors
    Brian M. Linhares, Jolanta E. Grembecka, Tomasz Cierpicki · 2020 · Future Medicinal Chemistry
35. Targeting Chromatin Complexes in Myeloid Malignancies and Beyond: From Basic Mechanisms to Clinical Innovation
    Florian Perner, Scott A. Armstrong · 2020 · Cells
36. 2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity
    Meena Kusi, Maryam Zand, Li‐Ling Lin, Meizhen Chen, Anthony Lopez, Chun-Lin Lin, Chiou‐Miin Wang, Nicholas L. L. Lucio, Nameer B. Kirma, Jianhua Ruan et al. · 2022 · Cell Reports
37. PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen
    Samantha L. Tinsley, Brittany L. Allen-Petersen · 2022 · NAR Cancer
38. Cancer plasticity: Investigating the causes for this agility
    Shubhraneel Saha, Nikita Pradhan, B Neha, Ravikiran Mahadevappa, Shilpi Minocha, Saran Kumar · 2022 · Seminars in Cancer Biology
39. H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy
    Chu Xiao, Tao T. Fan, Yujia Zheng, He Tian, Ziqin Deng, Jingjing Liu, Chunxiang Li, Jié He · 2023 · Journal for ImmunoTherapy of Cancer
40. How gallic acid regulates molecular signaling: role in cancer drug resistance
    Samira Hassani, Fahimeh Ghanbari, Marzieh Lotfi, Waqas Alam, Michael Aschner, Jelena B. Popović‐Djordjević, Seyed Hossein Shahcheraghi, Haroon Zaman Khan · 2023 · Medical Oncology
41. Epigenetic reprogramming: A key mechanism driving therapeutic resistance
    Anjali V. Sheahan, Leigh Ellis · 2018 · Urologic Oncology Seminars and Original Investigations
42. Genetic Mosaicism and Cancer: Cause and Effect
    A. V. Lichtenstein · 2018 · Cancer Research
43. Links between Serine Biosynthesis Pathway and Epigenetics in Cancer Metabolism
    HaEun Kim, Yoon Jung Park · 2018 · Clinical Nutrition Research
44. Epigenetic Changes as a Target in Aging Haematopoietic Stem Cells and Age-Related Malignancies
    Sonja C. Buisman, Gerald de Haan · 2019 · Cells
45. Pathogenic diversity of RNA variants and RNA variation-associated factors in cancer development
    Hee Doo Yang, Suk Woo Nam · 2020 · Experimental & Molecular Medicine
46. Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors
    Nevena B. Ognjenovic, Meisam Bagheri, Gadisti Aisha Mohamed, Ke Xu, Youdinghuan Chen, Mohamed-Ashick M. Saleem, Meredith S. Brown, Shivashankar Hiriyur Nagaraj, Kristen E. Muller, Scott A. Gerber et al. · 2020 · Developmental Cell
47. The transcription factor code: a beacon for histone methyltransferase docking
    Guillem Torcal Garcia, Thomas Graf · 2021 · Trends in Cell Biology
48. KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis
    Tingwei Guo, Xia Han, Jinzhi He, Jifan Feng, Junjun Jing, Eva Janečková, Jie Lei, Thach‐Vu Ho, Jian Xu, Yang Chai · 2022 · eLife
49. Extrachromosomal Circular DNA: A New Target in Cancer
    Pan Wu, Yuhang Liu, Ruijia Zhou, Lingyun Liu, Hongli Zeng, Fang Xiong, Shanshan Zhang, Zhaojian Gong, Wenling Zhang, Can Jie Guo et al. · 2022 · Frontiers in Oncology
50. Epigenetics Regulates Antitumor Immunity in Melanoma
    Yuhan Chen, Xiuli Yi, Ningyue Sun, Weinan Guo, Chunying Li · 2022 · Frontiers in Immunology
51. RETRACTED: The Emerging Role of Epigenetics in Metabolism and Endocrinology
    Belay Zeleke Sibuh, Sameer Quazi, Hrithika Panday, Ritika Parashar, Niraj Kumar Jha, Runjhun Mathur, Saurabh Kumar Jha, Pankaj Taneja, Abhimanyu Kumar Jha · 2023 · Biology · Retracted
52. How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?
    Inês Mendes, Nuno Vale · 2023 · International Journal of Molecular Sciences
53. Human Endogenous Retrovirus K in the Crosstalk Between Cancer Cells Microenvironment and Plasticity: A New Perspective for Combination Therapy
    Emanuela Balestrieri, Ayele Argaw-Denboba, Alessandra Gambacurta, Chiara Cipriani, Roberto Bei, Annalucia Serafino, Paola Sinibaldi Vallebona, Claudia Matteucci · 2018 · Frontiers in Microbiology
54. Minireview: The Epigenetic Modulation of KISS1 in Reproduction and Cancer
    Maria Letizia Motti, Rosaria Meccariello · 2019 · International Journal of Environmental Research and Public Health
55. Degradation of BRD4 - a promising treatment approach not only for hematologic but also for solid cancer.
    Karin Bauer, Anna Sophie Berghoff, Matthias Preusser, Gerwin Heller, Christoph Carl Zielinski, Peter Valent, Thomas W. Grunt · 2021 · PubMed Central
56. Limited mutagenicity of electronic cigarettes in mouse or human cells in vitro
    Stella Tommasi, Steven Bates, Rachel Z. Behar, Prue Talbot, Ahmad Besarati Nia · 2017 · Lung Cancer
57. Hepatic adaptation to chronic metabolic stress primes tumorigenesis
    Constantine N. Tzouanas, Jessica E.S. Shay, Marc Samuel Sherman, Adam J. Rubin, Benjamin E. Mead, Tyler T. Dao, Junyan Tao, Brandon M. Lehrich, George M. Eng, Jeffrey Patterson-Fortin et al. · 2025 · Cell
58. Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology
    Elisabet Cuyàs, Sara Verdura, Begoña Martı́n-Castillo, Javier Abel Menéndez · 2021 · Frontiers in Oncology
59. Functional characterization of RebL1 highlights the evolutionary conservation of oncogenic activities of the RBBP4/7 orthologue in Tetrahymena thermophila
    Syed Nabeel‐Shah, Jyoti Garg, Alejandro Saettone, Kanwal Ashraf, Hyunmin Lee, Suzanne Wahab, Nujhat Ahmed, Jacob L. Fine, Joanna Derynck, Shuye Pu et al. · 2021 · Nucleic Acids Research
60. p53-intact cancers escape tumor suppression through loss of long noncoding RNA Dino
    Christina B Marney, Erik Steven Anderson, Mutayyaba Adnan, Kai-Lin Peng, Ya Hu, Nils Weinhold, Adam M. Schmitt · 2021 · Cell Reports
61. Expansion microscopy allows high resolution single cell analysis of epigenetic readers
    Aline Acke, Siska Van Belle, Boris Louis, Raffaele Vitale, Susana Rocha, Thierry Voet, Zeger Debyser, Johan Hofkens · 2022 · Nucleic Acids Research
62. PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy?
    Clemens Zwergel, Rossella Fioravanti, Antonello Mai · 2022 · Drug Discovery Today
63. The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes
    Mette Louise Trempenau, Mikkel Bruhn Schuster, Sachin Pundhir, Mafalda Araújo, Adrija Kalviša, Marta Cecylia Tapia, Jinyu Su, Ying Chun Ge, Bauke de Boer, Alexander Balhuizen et al. · 2023 · Leukemia
64. MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer
    Yoshihiro Morimoto, Nami Yamashita, Haruka Hirose, Atsushi Fushimi, Naoki Haratake, Tatsuaki Daimon, Atrayee Bhattacharya, Rehan Ahmad, Yozo Suzuki, Hidekazu Takahashi et al. · 2023 · Cancer Letters
65. Intratumoral Heterogeneity in Lung Cancer
    Xiaodi Lv, Zixian Mao, Xianjun Sun, Baojun Liu · 2023 · Cancers
66. Metabolic dependencies of metastasis-initiating cells in female breast cancer
    C. Megan Young, Laurent Beziaud, Pierre Dessen, Angela Madurga Alonso, Albert Santamaria‐Martínez, Joerg Huelsken · 2023 · Nature Communications
67. Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer
    Rashmi Bharti, Goutam Dey, Debjit Khan, Alex Myers, Olivia G. Huffman, Caner Saygin, Chad Braley, Elliott G. Richards, Naseer Sangwan, Belinda B. Willard et al. · 2024 · Molecular Cancer
68. Epigenetic regulation of vascular smooth muscle cell phenotypes in atherosclerosis
    Jordi Lambert, Helle Færk Jørgensen · 2024 · Atherosclerosis
69. The Hallmarks of Cancer as Eco-Evolutionary Processes
    Ranjini Bhattacharya, Stanislav S. Avdieiev, Anuraag Bukkuri, Christopher J. Whelan, Robert A. Gatenby, Kenneth Yee Tsai, Joel S. Brown · 2025 · Cancer Discovery
70. The interplay of DNA damage, epigenetics and tumour heterogeneity in driving cancer cell fitness
    Célia D. Rouault, Emmanuelle Charafe‐Jauffret, Christophe Ginestier · 2025 · Nature Communications
71. Multiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator Event
    Jean‐Pascal Capp, Régis Bataille · 2018 · Frontiers in Oncology
72. Cis-Acting Factors Causing Secondary Epimutations: Impact on the Risk for Cancer and Other Diseases
    Miguel Ruiz-de la Cruz, Aldo Hugo De La Cruz-Montoya, Ernesto Arturo Rojas-Jiménez, Héctor Martínez-Gregorio, Clara Estela Díaz Velásquez, Jimena Paredes de la Vega, Fidel de la Cruz Hernández‐Hernández, Felipe Vaca‐Paniagua · 2021 · Cancers
73. New Tools for Lineage Tracing in Cancer In Vivo
    Matthew G. Jones, Dian Yang, Jonathan S. Weissman · 2023 · Annual Review of Cancer Biology
74. Liquid biopsies for cancer: From bench to clinic
    Zhenhui Chen, Chenghao Li, Yue Zhou, Yinghao Yao, Jiaqi Liu, Min Wu, Jianzhong Su · 2023 · MedComm
75. Loss of tumor suppressors promotes inflammatory tumor microenvironment and enhances LAG3+T cell mediated immune suppression
    Sara Zahraeifard, Zhiguang Xiao, Jae Young So, Abdul Ahad, Selina Montoya, Woo Yong Park, Trinadharao Sornapudi, Tiffany Andohkow, Abigail Read, Noémi Kedei et al. · 2024 · Nature Communications
76. Mechanical regulation of metabolism, epigenetics, and their interplay
    Hoonsik Nam, Gyusang Yu, Seor I Ahn, Sungmin Nam · 2026 · npj Biomedical Innovations.
77. Cancer systems immunology
    Nathan Edward Reticker-Flynn, Edgar G. Engleman · 2020 · eLife
78. Epigenetic regulation of cancer stem cell and tumorigenesis
    Kezhou Zhu, Victoria K. Xie, Suyun Huang · 2020 · Advances in cancer research
79. Regulating Tumor N6‐Methyladenosine Methylation Landscape using Hypoxia‐Modulating OsSx Nanoparticles
    Yue Zheng, Yu‐Yi Ling, Dongyang Zhang, Cai‐Ping Tan, Hang Zhang, Gang Yang, Hongsheng Wang, Liang‐Nian Ji, Zong‐Wan Mao · 2020 · Small
80. Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states
    Kaichun Li, Enrico Girardi, Felix Kartnig, Sarah Grosche, Tea Pemovska, Johannes W. Bigenzahn, Ulrich Goldmann, Vitaly Sedlyarov, Ariel Bensimon, Sandra Schick et al. · 2021 · Nature Metabolism
81. Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
    Alba Loras, Cristina Segovia, José Luis Ruiz-Cerdá · 2021 · Cancers
82. Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis
    Yujuan Jin, Qiqi Zhao, Weikang Zhu, Yan Feng, Tian Xiao, Peng Zhang, Liyan Jiang, Yingyong Hou, Chenchen Guo, Hsin‐Yi Huang et al. · 2021 · National Science Review
83. PRMT5-mediated methylation of STAT3 is required for lung cancer stem cell maintenance and tumour growth
    Yoshinori Abe, Takumi Sano, Naoki Otsuka, Masashi Ogawa, Nobuyuki Tanaka · 2024 · Communications Biology
84. Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types
    Sucharitha Iyer, Sunita Kishore Agarwal · 2018 · Journal of Molecular Endocrinology
85. Aging and cancer: Is glucose a mediator between them?
    Alexey G. Golubev, Vladimir Nikolaevich Anisimov · 2019 · Oncotarget
86. A deep-learning model for characterizing tumor heterogeneity using patient-derived organoids
    Kosuke Takagi, Motoki Takagi, Gen Hiyama, Kazuhito Goda · 2024 · Scientific Reports
87. Chromatin-based memory as a self-stabilizing influence on cell identity
    Charles C. Bell, Geoffrey J. Faulkner, Omer Gilan · 2024 · Genome biology
88. Lactate and lactylation: emerging roles in autoimmune diseases and metabolic reprogramming
    Wenjun Liu, Ruhui Yang, Yuxin Zhan, Xuanyu Yang, Haimin Zeng, Bofan Chen, Jiahao Zeng, Tenglong Hu, Jie Hu, Qi Xiao et al. · 2025 · Frontiers in Immunology
89. The Roles of Lactate and Lactylation in Diseases Related to Mitochondrial Dysfunction
    Fei Ma, Wei Yu · 2025 · International Journal of Molecular Sciences
90. Viral Status Predicts the Patterns of Genome Methylation and Decitabine Response in Merkel Cell Carcinoma
    Paul W. Harms, Monique Elise Verhaegen, Josh N. Vo, Jean Ching-Yi Tien, Drew W. Pratt, Fengyun Su, Saravana Mohan Dhanasekaran, Xuhong Cao, Doris Mangelberger, Julia J. Van Goor et al. · 2021 · Journal of Investigative Dermatology
91. Characteristic Hallmarks of Aging and the Impact on Carcinogenesis
    Marco Fiore, Sergio Amedeo Terracina, Giampiero Ferraguti, Carla Petrella, Sabina Maria Bruno, Giovanna Blaconà, Maria Grazia Di Certo, Antonio Minni, Antonio Greco, Angela Musacchio et al. · 2022 · Current Cancer Drug Targets
92. An Epigenetic LINE-1-Based Mechanism in Cancer
    Patrizia Lavia, Ilaria Sciamanna, Corrado Spadafora · 2022 · International Journal of Molecular Sciences
93. A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer
    Sravani Keerthi Ramisetty, Prakash Kulkarni, S. Bhattacharya, Arin Nam, Sharad S. Singhal, Linlin Guo, Tamara Mirzapoiazova, Bolot Mambetsariev, Sandeep Mittan, Jyoti Dhar Malhotra et al. · 2023 · Journal of Clinical Medicine
94. DNAJA4 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma via PSMD2-mediated MYH9 degradation
    Qun Zhang, Ping Feng, Xun-Hua Zhu, Shi-Qing Zhou, Mingliang Ye, Xiaojing Yang, Sha Gong, Sheng‐Yan Huang, Xi-Rong Tan, Shiwei He et al. · 2023 · Cell Death and Disease
95. A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Roberta Noberini, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2023 · Clinical Epigenetics
96. The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma
    Muzhou Wu, Ailish M. Hanly, Frederick Thomas Gibson, Robert J. Fisher, Samantha Rogers, Kihyun Park, Angelina Zuger, Kevin Kuang, Jay H. Kalin, Sarah E. Nocco et al. · 2024 · Journal of Clinical Investigation
97. Bivalent chromatin: a developmental balancing act tipped in cancer
    Eleanor Glancy, Natalie Choy, Mélanie A. Eckersley-Maslin · 2024 · Biochemical Society Transactions
98. KDM3B suppresses APL progression by restricting chromatin accessibility and facilitating the ATRA-mediated degradation of PML/RARα
    Xinrui Wang, Huiyong Fan, Congling Xu, Guojuan Jiang, Haiwei Wang, Ji Zhang · 2019 · Cancer Cell International
99. Proline-rich 11 (PRR11) drives F-actin assembly by recruiting the actin-related protein 2/3 complex in human non-small cell lung carcinoma
    Lian Zhang, Ying Zhang, Yunlong Lei, Zhili Wei, Yi Li, Yingxiong Wang, Youquan Bu, Chun‐Dong Zhang · 2020 · Journal of Biological Chemistry
100. Evaluation of the Epigenetic Demethylation of NRF2, a Master Transcription Factor for Antioxidant Enzymes, in Colorectal Cancer
     Zahra Taheri, Hamid Asadzadeh Aghdaei, Shiva Irani, Mohammad Hossein Modarressi, Zahra Noormohammadi · 2020 · Reports of Biochemistry and Molecular Biology